Physicochemical determinants of beryllium toxicity using in vitro and in vivo models
This presentation is the property of its rightful owner.
Sponsored Links
1 / 33

Physicochemical Determinants of Beryllium Toxicity using in vitro and in vivo Models PowerPoint PPT Presentation


  • 77 Views
  • Uploaded on
  • Presentation posted in: General

Physicochemical Determinants of Beryllium Toxicity using in vitro and in vivo Models. Gregory L. Finch, PhD Drug Safety Evaluation Pfizer Global Research & Development Groton, CT June 25/26, 2002 Beryllium Research Symposium, Bethesda MD

Download Presentation

Physicochemical Determinants of Beryllium Toxicity using in vitro and in vivo Models

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Physicochemical determinants of beryllium toxicity using in vitro and in vivo models

Physicochemical Determinants of Beryllium Toxicity using in vitro and in vivo Models

Gregory L. Finch, PhD

Drug Safety Evaluation

Pfizer Global Research & Development

Groton, CT

June 25/26, 2002

Beryllium Research Symposium, Bethesda MD

Acknowledgement: Most of the research presented today was conducted at Inhalation Toxicology Research Institute [LRRI], Albuquerque, NM

Be Research Symposium, GL Finch


Cbd an occupational health mystery

CBD: An occupational health mystery

Who?

  • current screening reveals many sensitized and diseased pts

  • only “susceptible” individuals appear to get CBD

    What?

  • granulomatous lesions with pronounced TH lymphocytic component, with pronounced Be-specific reactivity

  • a debilitating lung disease

    When?

  • a widely varying latency period following Be exposure; preceded by sensitization

    Where?

  • mostly occupational following exposure to various Be forms

  • no clear dose-response relationship has been defined

    Why?

  • an MHC-II restricted response

  • component of genetic susceptibility

  • importance of role of Be physicochemical form

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Model of Be Interaction with Immune System

From Newman, 1993

Be Research Symposium, GL Finch


Selected observations in role of physicochemical form in cbd

Selected observations in role of physicochemical form in CBD

  • There are a wide variety of physicochemical forms encountered

    • Natural occuring mineral

    • Various “soluble”/”insoluble” forms in processing

    • Mostly insoluble forms delivered to end users

  • Early experience:

    • More soluble forms generally lead to acute Be disease

    • More insoluble forms generally lead to CBD

    • No exposure-dose-response apparent

  • Exposure-response relationships are now being revealed

    • CBD more likely following exposure to relatively insoluble forms

    • apparent excess risk for certain occupations/processes

Be Research Symposium, GL Finch


How can in vitro in vivo models help

How can in vitro/in vivo models help?

  • Understanding exposure-dose-response relationships

    • role of physicochemical form

    • acute, episodic, or chronic exposures

    • Linkage to health effects

  • Understanding pathogenesis of response

    • detailed characterization

    • manipulated and/or knock-in/out models

  • Seeking therapeutic intervention

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Lovelace database on the properties and health effects of beryllium aerosols

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Lovelace database on the properties and health effects of beryllium aerosols

Be Research Symposium, GL Finch


Physicochemical properties and in vitro characteristics

Physicochemical properties and in vitro characteristics

  • Laboratory-produced preparations

    • BeO: produced with 7Be radiolabel and fired at 500 or 1000oC

    • Be metal: size-fractionated using an aerosol cyclone

  • “Field” preparations

    • Sawing/milling of alloys

    • Laser vaporization of Be metal

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Be Metal

Ni-Be Alloy

Cu-Be Alloy

Softer alloys yielded relatively more fine particles with identical machining processes

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Beryllium Metal Particles

Separated by an Aerosol Cyclone

Similarities: particle morphology

Differences: physical and aerodynamic size; specific surface area

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Be Metal Particles Have an Oxide Surface Layer

Initial dissolution behavior

might be similar for

Be and BeO

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Solubility in an acidic environment

Low fired BeO is more soluble than high fired or metal in an acidic environment

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Solubility in a simulated lung extracellular fluid

BeO is more soluble than Be in simulated lung fluid

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Toxicity to Canine Alveolar Macrophages

Toxicity increases with solubility of the Be material

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

In Vitro Toxicity based on:

MassSurface Area

Normalization by “surface area dose” resulted in comparable toxicity

Be Research Symposium, GL Finch


Large animal models of be biokinetics and be induced toxicity studies in dogs

Large animal models of Be biokinetics and Be-induced toxicity – Studies in Dogs

  • Respirable preparations of 7BeO fired at either 500o or 1000oC were used

  • Dogs were exposed once by inhalation to achieve either low [17 g/kg] or high [50 g/kg] initial lung burdens [ILBs]

  • Dogs were sacrificed up through 365 days post-exposure

    • Biokinetic evaluation

    • Lung histopathology

  • A companion group was evaluated through 730 days post-exposure

    • Period lung lavage for cytology and lymphocyte simulation

    • Dogs were re-exposed at 2-yr then followed for an additional 210 days

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

BeO Clearance/Translocation in Dogs

LUNGS

Lower-fired BeO cleared more rapidly from lung, and persisted at higher levels in extrapulmonary compartments

Be Research Symposium, GL Finch


Lung lesion in beo exposed dogs

Lung lesion in BeO-exposed dogs

Be Research Symposium, GL Finch


Interstitial granuloma in beo exposed dogs

Interstitial granuloma in BeO-exposed dogs

Be Research Symposium, GL Finch


Relative severity of pulmonary lesions in beo exposed dogs

Relative severity of pulmonary lesions in BeO-exposed dogs

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Influence of BeO Temperature History

on the Influx of Neutrophils

Be Research Symposium, GL Finch


Lymphocyte numbers and sis in dogs

Lymphocyte numbers and SIs in Dogs

Be Research Symposium, GL Finch


Physicochemical determinants of beryllium toxicity using in 1264179

Lymphocyte SIs following re-exposure to BeOGrouped by first exposure to high or low ILBs of 500 or 1000oBeO

Be Research Symposium, GL Finch


Summary of results in dogs

Summary of results in dogs

  • Compared to high fired BeO, low-fired BeO:

    • cleared from lungs more rapidly

    • produced more marked inflammatory response

    • Increased numbers of lymphocytes

    • Increased lymphocyte stimulation indices

  • Responses peaked several months after exposure

  • Previous exposure history did not influence responses to a 2nd exposure to low-fired BeO, and the effects were not cumulative

Be Research Symposium, GL Finch


Comparative toxicity of be metal vs beo in monkeys

Comparative toxicity of Be metal vs. BeO in monkeys

  • Study used low-fired BeO [500oC] and size fractionated Be metal

  • Animals were exposed by bronchoscopic, intrabronchiolar instillation

  • Regimen 1:

    • Graded doses of BeO [saline, 2.5, 12.5, 37.5 g] or Be metal [saline, 1, 50, 150 g] into different lung lobes

    • Doses based on estimated dissolution over 80 dpe

    • Histological evaluation of granulomas guided dose selection for regimen 2

  • Regimen 2:

    • Single doses of 12.5 g BeO or 50 g Be metal

    • Lavages through 120 dpe and sacrifice at 180 dpe

Be Research Symposium, GL Finch


Be induced lesions in monkey

Be-induced lesions in monkey

Be Research Symposium, GL Finch


Be induced lesion in monkey

Be-induced lesion in monkey

Be Research Symposium, GL Finch


Lymphocytes recovered by lavage

Lymphocytes recovered by lavage

Be Research Symposium, GL Finch


Lymphocyte proliferation

Lymphocyte proliferation

Be Research Symposium, GL Finch


Large animal studies summary

Large animal studies - summary

  • Clear differences between BeO [and temperature history] and Be metal demonstrated

  • Biologically:

    • Granulomatous lesions were produced

    • Lymphocytes were increased in number

    • Increased lymphocyte proliferation demonstrated

  • However:

    • Biological responses were not progressive

    • Additional efforts were devoted to murine studies using Be metal

Be Research Symposium, GL Finch


Summary of importance of physicochemical form

Summary of importance of physicochemical form

  • It is important for “relatively insoluble” particles

    • The amount of surface presented appears to control dissolution and toxicity

    • Form and preparation influences disposition, biokinetics, and in vivo toxicity

  • Exposure-dose-response need not be rejected

    • Just need to look in the right place

    • Compare “equivalent” exposures

    • Account for host factors, genetic susceptibility

Be Research Symposium, GL Finch


Conclusion a hypothesis

Conclusion – a hypothesis

  • A hypothesis: there is a critical balance in lung between solubility and retained or newly deposited dose

    • Solubility/stimulus: needed to release Be++ to produce antigenic stimulus and induction of sensitization

    • Retention/re-challenge: needed to provide long term challenge depot of Be++ once sensitization is achieved

    • Both form/solubility and chronicity of exposure undoubtably work in concert – with host factors - to drive CBD

Be Research Symposium, GL Finch


Acknowledgements

LRRI Principal Investigators:

Greg Finch

Mark Hoover

Pat Haley

LRRI Scientists

Ed Barr

Bill Bechtold

Dave Bice

Fletcher Hahn

Charles Hobbs

Tom March

Bruce Muggenburg

Kris Nikula

Bill Griffith

Janet Benson

Steve Belinsky

Technical Support Staff:

Lee Blair

Dee Esparza

Anna Holmes

Applied Toxicology Group

Exposure Operations Group

Animal Care Unit

Necropsy/Histology Lab

Lung Cancer Program

Collaborations:

Bill Carlton, DVM, Purdue

Alan Rebar, DVM, Purdue

Funding from the US Department of Energy

Acknowledgements

Be Research Symposium, GL Finch


  • Login